-
1
Reduction of monoclonal antibody viscosity using interpretable machine learning
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
2
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
3
-
4
Electrostatic properties of human germlines and biodistribution of small biologics
Published 2024-12-01Subjects: Get full text
Article -
5
Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors
Published 2024-12-01Subjects: Get full text
Article -
6
Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
7
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
Published 2024-12-01Subjects: Get full text
Article -
8
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
9
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors
Published 2024-12-01Subjects: Get full text
Article -
10
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
11
Engineered ipilimumab variants that bind human and mouse CTLA-4
Published 2025-12-01Subjects: “…Antibody engineering…”
Get full text
Article -
12
Biparatopic antibodies: therapeutic applications and prospects
Published 2024-12-01Subjects: “…Antibody engineering…”
Get full text
Article